Bioneer Corporation (KOSDAQ:064550)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,900
+490 (3.95%)
At close: Feb 27, 2026
-15.74%
Market Cap 332.95B
Revenue (ttm) 320.69B
Net Income (ttm) -8.97B
Shares Out 25.81M
EPS (ttm) -348.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 165,605
Average Volume 130,483
Open 12,700
Previous Close 12,410
Day's Range 12,450 - 13,140
52-Week Range 11,650 - 17,950
Beta 0.11
RSI 49.65
Earnings Date Mar 18, 2026

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 367
Stock Exchange KOSDAQ
Ticker Symbol 064550
Full Company Profile

Financial Performance

In 2024, Bioneer's revenue was 293.98 billion, an increase of 11.68% compared to the previous year's 263.24 billion. Losses were -20.58 billion, 94.4% more than in 2023.

Financial Statements

News

There is no news available yet.